Two factors were probably critical to thesuccess of the approach: the use of oncogenes commonly mutated or amplified inERα + breast cancer, and the use of culture medium favoring ERBB3 over EGFRsignaling to prevent squamous metaplasia invitro. The gene discussed is ERBB3; the disease is breast carcinoma.